Oncopharmacology in Interventional Radiology
- PMID: 36406031
- PMCID: PMC9671678
- DOI: 10.1055/s-0042-1758076
Oncopharmacology in Interventional Radiology
Abstract
The broad scope of malignancies treated in interventional oncology is mirrored by the breadth of oncotherapeutics, drugs used to treat cancer. Many of these treatments are administered endovascularly, though a group of therapies can be delivered percutaneously. Perhaps the best taxonomy of oncotherapeutics is based on their biological inactivity or activity and the mechanism by which they interact with treated and targeted tissues. As the fields of interventional oncology and oncotherapeutics continue to grow and expand, this framework may provide a more organized approach in helping distinguish and select the best therapy for patients.
Keywords: chemotherapy; endovascular; interventional radiology; oncology; oncotherapeutics; percutaneous.
Thieme. All rights reserved.
Conflict of interest statement
Conflict of Interest None declared.
References
-
- Ramsey D E, Kernagis L Y, Soulen M C, Geschwind J F.Chemoembolization of hepatocellular carcinoma J Vasc Interv Radiol 200213(9, Pt 2):S211–S221. - PubMed
-
- Marelli L, Stigliano R, Triantos C. Transarterial therapy for hepatocellular carcinoma: which technique is more effective? A systematic review of cohort and randomized studies. Cardiovasc Intervent Radiol. 2007;30(01):6–25. - PubMed
-
- Case M D, Slovak R, Raja J, Kim H S. Interventional Oncology in Immuno-Oncology Part 2: Transcatheter therapies. Dig Dis Interv. 2019;03(02):155–162.
Publication types
Grants and funding
LinkOut - more resources
Full Text Sources
Research Materials
